AbCellera Biologics Inc.: cash_and_equivalents
| Value | {"unit": "CAD", "value": 55600000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9c137959-2708-4432-a1ea-87154de8052a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-008689Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/cash-and-equivalents/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9c137959-2708-4432-a1ea-87154de8052a
History
- supersedes {"amount": 156325000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001628280-25-008689)